Healthcare - Biotechnology - NASDAQ - US
$ 2.21
-0.897 %
$ 1.9 M
Market Cap
-0.14
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
515.74%
Net Income
Estimate
172.75%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Phio Pharmaceuticals Corp.
PHIO has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart PHIO
EBIT FORECAST
EBIT Forecast Chart PHIO
NET INCOME FORECAST
Net Income Chart PHIO